［1］Fink SL，Cookson BT.Apoptosis，pyroptosis，and necrosis：Mechanistic description of dead and dying eukaryotic cells［J］.Infect Immun，2005，73(4)：1907-1916.
［2］Cookson BT，Brennan MA.Pro-inflammatory programmed cell death［J］.Trends Microbiol，2001，9(3)：113-114.
［3］Shi J，Zhao Y，Wang K，et al.Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death［J］.Nature，2015，526(7575)：660-665.
［4］Aglietti RA，Estevez A，Gupta A，et al.GsdmD p30 elicited by caspase-11 during pyroptosis forms pores in membranes［J］.Proc Natl Acad Sci USA，2016，113(28)：7858-7863.
［5］Ding J，Wang K，Liu W，et al.Pore-forming activity and structural autoinhibition of the gasdermin family［J］.Nature，2016，535(7610)：111-116.
［6］Shi J，Gao W，Shao F.Pyroptosis：Gasdermin-mediated programmed necrotic cell death［J］.Trends Biochem Sci，2017，42(4)：245-254.
［7］Galluzzi L，Vitale I，Aaronson SA，et al.Molecular mechanisms of cell death：Recommendations of the nomenclature committee on cell death 2018［J］.Cell Death Differ，2018，25(3)：486-541.
［8］Wang Y，Gao W，Shi X，et al.Chemotherapy drugs induce pyroptosis through caspase-3 cleavage of a gasdermin［J］.Nature，2017，547(7661)：99-103.
［9］Mascarenhas DPA，Cerqueira DM，Pereira MSF，et al.Inhibition of caspase-1 or gasdermin-D enable caspase-8 activation in the Naip5/NLRC4/ASC inflammasome［J］.PLoS Pathog，2017，13(8)：e1006502.
［10］Orning P，Weng D，Starheim K，et al.Pathogen blockade of TAK1 triggers caspase-8-dependent cleavage of gasdermin D and cell death［J］.Science，2018，362(6418)：1064-1069.
［11］Sarhan J，Liu BC，Muendlein HI，et al.Caspase-8 induces cleavage of gasdermin D to elicit pyroptosis during Yersinia infection［J］.Proc Natl Acad Sci USA，2018，115(46)：E10888-E10897.
［12］Fujikawa K，Shiraki K，Sugimoto K，et al.Reduced expression of ICE/caspase1 and CPP32/caspase3 in human hepatocellular carcinoma［J］.Anticancer Res，2000，20(3B)：1927-1932.
［13］Chu Q，Jiang Y，Zhang W，et al.Pyroptosis is involved in the pathogenesis of human hepatocellular carcinoma［J］.Oncotarget，2016，7(51)：84658-84665.
［14］Yan W，Chang Y，Liang X，et al.High-mobility group box 1 activates caspase-1 and promotes hepatocellular carcinoma invasiveness and metastases［J］.Hepatology，2012，55(6)：1863-1875.
［15］Higai K，Miyazaki N，Azuma Y，et al.Interleukin-1beta induces sialyl Lewis X on hepatocellular carcinoma HuH-7 cells via enhanced expression of ST3Gal IV and FUT VI gene［J］.FEBS Lett，2006，580(26)：6069-6075.
［16］Wei Q，Mu K，Li T，et al.Deregulation of the NLRP3 inflammasome in hepatic parenchymal cells during liver cancer progression［J］.Lab Invest，2014，94(1)：52-62.
［17］Sonohara F，Inokawa Y，Kanda M，et al.Association of inflammasome components in background liver with poor prognosis after curatively-resected hepatocellular carcinoma［J］.Anticancer Res，2017，37(1)：293-300.
［18］Tanaka Y，Furuta T，Suzuki S，et al.Impact of interleukin-1b genetic polymorphisms on the development of hepatitis C virus-related hepatocellular carcinoma in Japan［J］.J Inffect Dis，2003（187）：1822-1825.
［19］Wang Y，Kato N，Hoshida Y，et al.Interleukin-1b gene polymorphisms associated with hepatocellular carcinoma in hepatitis C virus infection［J］.Hepatology，2003，37(1)：65-71.
［20］Hirankarn N，Kimkong I，Kummee P，et al.Interleukin-1beta gene polymorphism associated with hepatocellular carcinoma in hepatitis B virus infection［J］.World J Gastroenterol，2006，12(5)：776-779.
［21］Okamoto K，Ishida C，Ikebuchi Y，et al.The genotypes of IL-1 beta and MMP-3 are associated with the prognosis of HCV-related hepatocellular carcinoma［J］.Intern Med，2010，49(10)：887-895.
［22］Wei Q，Guo P，Mu K，et al.Estrogen suppresses hepatocellular carcinoma cells through ERbeta-mediated upregulation of the NLRP3 inflammasome［J］.Lab Invest，2015，95(7)：804-816.
［23］Fan SH，Wang YY，Lu J，et al.Luteoloside suppresses proliferation and metastasis of hepatocellular carcinoma cells by inhibition of NLRP3 inflammasome［J］.PLoS One，2014，9(2)：e89961.
［24］Shi X，Liu J，Ren L，et al.Nutlin-3 downregulates p53 phosphorylation on serine392 and induces apoptosis in hepatocellular carcinoma cells［J］.BMB Rep，2014，47(4)：221-226.
［25］Shi XL，Liu JL，Yu K，et al.Nutlin-3 promotes pyroptosis in SMMC-7721 cells［J］.Chin J Immuno，2017，33(7)：1014-1017.
［26］Yan JG.Radiofrequency ablation in the treatment of hepatocellular carcinoma：The observation of NLRP3 and IL-1β changes［J］.J Clin Med，2017，4(28)：5378.
［27］Jiang Z，Yao L，Ma H，et al.miRNA-214 inhibits cellular proliferation and migration in glioma cells targeting caspase 1 involved in pyroptosis［J］.Oncol Res，2017，25(6)：1009-1019.
［28］Zhang LL，Guo YJ，Zhao CN，et al.Effects and mechanism of miR-214 on hepatocellular carcinoma［J］.Asian Pac J Trop Med，2015，8(5)：392-398.
［29］Li H，Wang H，Ren Z.MicroRNA-214-5p inhibits the invasion and migration of hepatocellular carcinoma cells by targeting Wiskott-Aldrich syndrome like［J］.Cell Physiol Biochem，2018，46(2)：757-764.
［30］Wan J，Huang M，Zhao H，et al.A novel tetranucleotide repeat polymorphism within KCNQ1OT1 confers risk for hepatocellular carcinoma［J］.DNA Cell Biol，2013，32(11)：628-634.
［31］Li C，Miao R，Zhang J，et al.Long non-coding RNA KCNQ1OT1 mediates the growth of hepatocellular carcinoma by functioning as a competing endogenous RNA of miR-504［J］.Int J Oncol，2018(52)：1603-1612.
［32］Hu H，Yang L，Li L，et al.Long non-coding RNA KCNQ1OT1 modulates oxaliplatin resistance in hepatocellular carcinoma through miR-7-5p/ABCC1 axis［J］.Biochem Biophys Res Commun，2018，503(4)：2400-2406.
［33］Jin X，Jin H，Shi Y，et al.Long non-coding RNA KCNQ1OT1 promotes cataractogenesis via miR-214 and activation of the caspase-1 pathway［J］.Cell Physiol Biochem，2017，42(1)：295-305.
［34］Yang F，Qin Y，Wang Y，et al.LncRNA KCNQ1OT1 mediates pyroptosis in diabetic cardiomyopathy［J］.Cell Physiol Biochem，2018，50(4)：1230-1244.